Viking accelerates development of obesity drug that could rival Wegovy, Zepbound - STAT

0

25.07.2024 02:19

Top Stories (us) - Google News (ru) 

1. Viking accelerates development of obesity drug that could rival Wegovy, Zepbound  STAT
2. Viking Therapeutics stock jumps 20% after drugmaker moves weight loss injection to late-stage trial  CNBC
3. Viking Therapeutics Unveils Monthly Weight-Loss Shot, And Rocks Eli Lilly, Novo Nordisk  Investor's Business Daily
4. Viking stock climbs on obesity drug update (NASDAQ:VKTX)  Seeking Alpha
5. Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update  PR Newswire

Moscow.media

Частные объявления сегодня

Rss.plus

Все новости за 24 часа